Jazz Pharmaceuticals Plc - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated September 28, 2017 (filed October 3, 2017), discloses a material definitive agreement entered into by Jazz Pharmaceuticals, Inc. (JPI), a wholly-owned subsidiary of Jazz Pharmaceuticals Plc. The filing details a new commercial lease for a building to be constructed in Palo Alto, California.
Key Financial Metrics and Obligations
The filing outlines significant future financial commitments related to the new lease rather than historical performance metrics.
- Lease Term: Initial term of 12 years, commencing upon occupancy or 240 days after work commencement, whichever is earlier.
- Property Size: Approximately 99,000 to 100,000 square feet.
- Base Rent: $6.20 per square foot per month during the Initial Term.
- Total Base Rent: Approximately $103 million over the Initial Term (assuming 100,000 sq. ft.).
- Operating Expenses: Estimated at approximately $23 million over the Initial Term.
- Leasehold Improvements: Estimated cost of approximately $19 million, net of tenant improvement allowances.
- Renewal Options: Two options to extend for five years each at 95% of prevailing market rent.
Material Changes and Agreements
JPI entered into a lease with The Board of Trustees of the Leland Stanford Junior University for a new building at 3181 Porter Drive, Palo Alto, California. JPI is expected to occupy the building by the end of 2019. This agreement supplements existing leases held by JPI at 3170 Porter Drive and 3180 Porter Drive. The filing notes that JPI has an option to terminate the new lease upon the expiration of the initial 12-year term of the 3170 Lease, subject to a termination fee of three months' rent plus reimbursement of unamortized costs.
Outlook, Risks, and Contingencies
Management provided forward-looking statements regarding anticipated occupancy and cash expenditures. Key risks and contingencies identified include:
- Uncertainty regarding the ability to occupy the building when anticipated.
- Potential for rent and expenditure obligations to be incurred earlier than expected.
- Risk that estimated cash expenditures may exceed current projections.
- The Company's substantial outstanding debt service obligations, which require significant cash.
The Company explicitly states it undertakes no duty to update forward-looking statements based on new information or changes in expectations.
Investor Verification Checklist
- Verify the full text of the Commercial Lease when filed as an exhibit to the Form 10-Q for the quarter ended September 30, 2017.
- Monitor the Company's cash flow and debt service capacity given the substantial new long-term obligations.
- Track construction progress and the actual occupancy date relative to the projected end of 2019 timeline.
- Review the status of the existing 3170 Lease to understand the conditions for the early termination option of the new lease.